From diagnosis to ovulation induction. About premature ovarian failure;Du constat pathologique à l'obtention de l'ovulation. Le cas des déficiences ovariennes

Gynecologie Obstetrique et Fertilite

Volumn 29, Issue 1, 2001, Pages 39-48

  Barbarino Monnier, P ^a  

^a Maternite Regionale Universitaire   (France)

Author keywords

Ovulation induction; Premature ovarian failure

Indexed keywords

ESTROGEN; GONADORELIN; GONADOTROPIN;

AUTOIMMUNITY; FEMALE; HORMONE SUBSTITUTION; HUMAN; OVARY DISEASE; OVARY FUNCTION; OVULATION INDUCTION; PREGNANCY; REVIEW;

EID: 0035141046     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/S1297-9589(00)00049-7     Document Type: Short Survey

References (85)

1. Physiopathologie de l'insuffisance ovarienne prématurée: Faits et perspectives
2. Estimation of the distribution of age at natural menopause from prevalence data
3. Incidence of premature ovarian failure
4. Premature ovarian failure
5. Expression of c-kit at the W locus of mice in developing embryonic germ cells and presumptive melanoblasts
6. The germ cell deficient locus maps to mouse chromosome 11A2-3
7. Thymus and reproduction : Sex-linked dysgenesia of the gonad after neonatal thymectomy in mice
8. Thymic regulation of primate fetal ovarian-adrenal differentiation
9. Galactosemia: How does long-term treatment change the outcome?
10. Long-term prognosis in galactosemia: Results of a survey of 350 cases
11. Hypergonadotrophic hypogonadism in classical galactosemia, evidence for defective oogenesis
12. Resistant ovary syndrome with premature ovarian failure in a young woman with galactosemia
13. The resistant ovary syndrome in a patient with galactosemia: A clue to the natural history of ovarian failure
14. Reduction in oocyte number following prenatal exposure to a diet high in galactose
15. Gonadal function and ovarian galactose metabolism in classic galactosemia
16. The XYgonadal agenesis syndrome
17. Pregnancy in the Turner syndrome with only 45 X chromosomal constitution
18. Pregnancy and reproductive function in a patient with nonmosaic Turner Syndrome
19. Turner syndrome: The case of the missing sex chromosome
20. 45,X/46,XX mosaicism in patients with idiopathic premature ovarian failure
21. Premature ovarian failure
22. Review of 59 patients with hypergonadotrophic amenorrhoea
23. Balanced structural changes involving the human X: Effect on sexual phenotype
24. The critical region on the human Xq
25. Paracentric inversion X (q21.2q24) associated with mental retardation in males and normal ovarian function in females
26. Eleven X chromosome breakpoints associated with premature ovarian failure (POF) map to a 15-Mb YAC contig spanning Xq21
27. Premature ovarian failure and ovarian dysgenesis associated with balanced and unbalanced X-6 translocations, respectively: Implications for the investigation of ovarian failure
28. Balanced X; 22 translocation in a patient with premature ovarian failure
29. Premutation screening in women with premature ovarian failure
30. FRAXA premutations are not a cause of familial premature ovarian failure
31. A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: Evidence for conserved function in oogenesis and implications for human sterility
32. Primary amenorrhea and infertility due to a mutation in the β-subunit of follicle-stimulating hormone
33. Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone β-subunit gene
34. Isolated deficiency of follicle-stimulating hormone re-revisited
35. The genetics of XX gonadal dysgenesis
36. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure
37. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor
38. Testicular and ovarian resistance to luteinizing hormone caused by inactiving mutations of the luteinizing hormone receptor gene
39. An inactivating mutation of the luteinizing hormone mutation of the luteinizing hormone receptor causes amenorrhea in e 46, XX female
40. Blepharophimosis plus ovarian failure: A likely candidate for a contiguous gene syndrome
41. Five cases of Addison's disease with so-called atrophy of adrenal cortex
42. A clinical and immunological study of adrenocortical insufficiency (Addison's disease)
43. Immunological aspects of premature ovarian failure associated with idiopathic Addison's disease
44. Premature ovarian failure: Autoimmunity and natural history
45. Occult ovarian failure: A syndrome of infertility, regular menses, and elevated follicle-stimulating hormone concentrations
46. Is subclinical ovarian failure an autoimmune disease?
47. Low levels of serum inhibin A and inhibin B in women with hypergonadotropic amenorrhea and evidence of high levels of activin A in women with hypothalamic amenorrhea
48. Premature ovarian failure: Evidence of the immunologic component
49. Antibodies to cytoplasm of ova
50. Organ specific antibodies against ovary in patients with systemic lupus erythematosus
51. Auto-immunité et fécondation in vitro: Effets des multiponctions sur la prévalence des anticorps anti-ovaires
52. Antiovary antibodies, repeated attempts, and outcome of in vitro fertilization
53. Evidence of gonadal and gonadotropin antibodies in women with a suboptimal ovarian response to exogenous gonadotropin
54. Prevalence, specificity and significance of ovarian antibodies during spontaneous premature ovarian failure
55. Persistent progesterone production associated with autoimmune oophoritis
56. Autoimmune oophoritis: A histopathologic study of involved ovaries with immunologic characterization of the mononuclear cell infiltrate
57. Inhibition of follicle-stimulating hormone receptor binding by circulating immunoglobulins
58. Evidence for existence of immunoglobulins that block ovarian granulosa cell growth in vitro. A putative role in resistant ovary syndrome
59. High frequency of IgG antagonizing follicle-stimulating hormone-stimulated steroidegenesis in infertile women with a good response to exogenous gonadotropins
60. The further characterization of autoantibodies reactive with extra-adrenal steroid-producing cells in patients with adrenal disorders
61. Autoantibodies to zona pellucida: A possible cause for infertility in women
62. A method for specific detection of autoantibodies to the zona pellucida in infertile women
63. Anti-zona pellucida activity in human sera
64. Experimental immune oophoritis as a model for studying the thymus-ovary interaction. 1. Morphological studies
65. Autoimmune oophoritis
66. Autoimmune oophoritis associated with polycystic ovaries
67. Effect of combined removal of thymus and pituitary on post-natal ovarian follicular development in the mouse
68. Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction
69. Premature ovarian failure: An update
70. Follicle-stimulating hormone concentrations in relation to active and passive smoking
71. The effect of hysterectomy on the age at ovarian failure: Identification of a subgroup of women with premature loss of ovarian function and literature review
72. A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea
73. Suppression of gonadotrophin secretion does not reverse premature ovarian failure
74. Gonadotropin suppression for the treatment of karyotypically normal spontaneous premature ovarian failure: A controlled trial
75. Ovulation induction in premature ovarian failure: A placebo-controlled randomized trial combining pituitary suppression with gonadotropin stimulation
76. Gonadotropin-induced pregnancy following «premature ovarian failure»
77. Ovulation induction and pregnancies in 100 consecutive women with hypergonadotropic amenorrhea
78. Gonadotropins enhance HLA-DR antigen expression in human granulosa cells
79. Success in inducing ovulation in a case of premature ovarian failure using growth hormone-releasing hormone
80. A controlled study of danazol for the treatment of karyotypically normal spontaneous premature ovarian failure
81. Ovarian antibodies detected by immobilized antigen immunoassay in patients with premature ovarian failure
82. High-dose, short-term glucocorticoids for the treatment of infertility resulting from premature ovarian failure
83. Premature ovarian failure - The prognostic application of autoimmunity on conception after ovulation induction
84. Corticosteroids do not influence ovarian responsiveness to gonadotropins in patients with premature ovarian failure: A randomized, placebo-controlled trial